Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of Glucocorticoid-Induced Hyperglycemia (GIH)
NCT01810952Phase 4Completed
- Sponsor
- Baylor College of Medicine
- Start
- Sep 2010
- Primary completion
- Sep 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine, insulin lispro, insulin isophane in hyperglycemia, diabetes mellitus (DM), sponsored by Baylor College of Medicine. Started Sep 2010; status: completed.
02
Drugs
insulin glargineinsulin lisproinsulin isophane
03
Conditions
hyperglycemiadiabetes mellitus (DM)
Beyond the preview
Go deeper on NCT01810952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01810952.